Webinar: Clinical Trials - Information To Help You Plan Your Next Steps - POCTRN

null Webinar: Clinical Trials - Information To Help You Plan Your Next Steps

Webinar: Clinical Trials - Information To Help You Plan Your Next Steps


Clinical Trials are a critically important, yet complex, step toward bringing important point of care technologies to the patients who need them. Join us for our webinar when our speaker will discuss strategies that will help you plan your next steps.

Speakers

Erin Iturriaga, DNP, MSN, RN 

Program Officer/Clinical Trials Specialist

National Heart, Lung, and Blood Institute (NHLBI)

Chris Sasiela, PhD, RAC

Regulatory Specialist

National Heart, Lung, and Blood Institute (NHLBI)

When

This webinar took place Wednesday, October 30, 2019

View the Recording

Download Presentation A

Download Presentation B

This webinar is designed by the NIH Point of Care Technology Research Network (POCTRN) to provide relevant information to stakeholders interested in point-of-care technology research and development. POCTRN's goal is to develop technologies with clinical applications using a network model that enhances complementary strengths and builds multidisciplinary partnerships.

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADxsm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.

ABOUT RADx

In the News 

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests

NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests

The need for new test verification and regulatory support for innovative diagnostics

NIH-funded screening study builds case for frequent COVID-19 antigen testing

RADx partnerships speed new COVID testing

One Year of RADx Tech Success

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort 

Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology

Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test

RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative

NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration

The National Strategy From the COVID-19 Response and Pandemic Preparedness

Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced

The Need for More and Better Testing for COVID-19